These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2512138)

  • 21. Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model.
    Perrin-Guyomard A; Poul JM; Corpet DE; Sanders P; Fernández AH; Bartholomew M
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):151-60. PubMed ID: 15963836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some aspects of the gastrointestinal microflora of germfree mice associated with cultured microfloras.
    Koopman JP; Kennis HM; Stadhouders AM; De Boer H
    Lab Anim; 1983 Jul; 17(3):188-95. PubMed ID: 6678338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients.
    De Pauw BE; Donnelly JP; De Witte T; Nováková IR; Schattenberg A
    Bone Marrow Transplant; 1990 Mar; 5(3):179-82. PubMed ID: 2184908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation.
    Wiesner RH; Hermans PE; Rakela J; Washington JA; Perkins JD; DiCecco S; Krom R
    Transplantation; 1988 Mar; 45(3):570-4. PubMed ID: 3279582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of selective decontamination in the prevention of infection after accidental irradiation. A review.
    Brook I; Ledney GD
    Prehosp Disaster Med; 1993; 8(1):85-8. PubMed ID: 10155457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term prophylaxis of infection by selective decontamination in leukopenia and in mechanical ventilation.
    Clasener HA; Vollaard EJ; van Saene HK
    Rev Infect Dis; 1987; 9(2):295-328. PubMed ID: 3296099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin: an overview and prospective appraisal.
    Neu HC
    Am J Med; 1987 Apr; 82(4A):395-404. PubMed ID: 3578329
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of oral ciprofloxacin as selective intestinal decontaminant in cirrhosis.
    Borzio M; Salerno F; Saudelli M; Galvagno D; Piantoni L; Fragiacomo L
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):262-6. PubMed ID: 9646219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of ciprofloxacin alone and in combination with other antibiotics in a murine model of thigh muscle infection.
    Haller I
    Am J Med; 1987 Apr; 82(4A):76-9. PubMed ID: 3578333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in intestinal microflora following levofloxacin administration in laboratory animals].
    Ianniello F; Noviello S; Leone S; Esposito S; Lucisano A; Ciarcia R
    Infez Med; 2005 Sep; 13(3):168-74. PubMed ID: 17402182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of the fluoroquinolone antibiotics.
    Just PM
    Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective decontamination as an infection control measure.
    Emmerson AM
    J Hosp Infect; 1991 Apr; 17(4):241-2. PubMed ID: 1677649
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of ciprofloxacin in developing countries.
    Green S; Tillotson G
    Pediatr Infect Dis J; 1997 Jan; 16(1):150-9; discussion 160-2. PubMed ID: 9002127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained decrease of serum anti-galactose alpha 1-3-galactose antibodies in baboons by removing aerobic gram-negative bacteria from the bowel.
    Manez R; Diaz I; Centeno A; Gonzalez E; Hermida M; Blanco F; Davies HF; Katopodis A
    Transplant Proc; 1999; 31(1-2):947-8. PubMed ID: 10083419
    [No Abstract]   [Full Text] [Related]  

  • 36. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.
    Schito GC; Sanna A; Chezzi C; Ravizzola G; Leone F; Molinari G; Menozzi MG; Pirali F
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
    Itokazu GS; Quinn JP; Bell-Dixon C; Kahan FM; Weinstein RA
    Clin Infect Dis; 1996 Oct; 23(4):779-84. PubMed ID: 8909844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of new quinolones on the human gastrointestinal microflora.
    Nord CE
    Rev Infect Dis; 1988; 10 Suppl 1():S193-6. PubMed ID: 3279492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
    Dembry LM; Farrel PA; Orcutt DR; Gerrity LA; Andriole VT
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():35-42. PubMed ID: 9222068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.
    Van der Auwera P
    Infection; 1986; 14(3):142-4. PubMed ID: 2942489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.